About CCA Clinical Research
CCA Clinical Research is a company based in Cobham (United Kingdom) founded in 1988 was acquired by Atlantic Research Group in December 2018. CCA Clinical Research operates in a competitive market with competitors including Celerion, Altasciences, Ask Gene Pharma, iCardiac Technologies and Open Orphan, among others.
- Headquarter Cobham, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Atlantic Research Group
(Dec 04, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CCA Clinical Research
Detailed funding history for CCA Clinical Research
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in CCA Clinical Research
CCA Clinical Research has secured backing from 1 investor. Prominent investors backing the company include Atlantic Research Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Contract Research Organization for clinical trials in oncology, immunology, and neurology sectors.
|
Locked | Locked | Locked |
Investor details for CCA Clinical Research
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CCA Clinical Research
Investment portfolio details for CCA Clinical Research
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CCA Clinical Research
Detailed financials for CCA Clinical Research
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cca Clinical Research Comparisons
Peer comparison for CCA Clinical Research
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CCA Clinical Research
CCA Clinical Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celerion, Altasciences, Ask Gene Pharma, iCardiac Technologies and Open Orphan, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Early clinical research services are provided for drug development.
|
|
| Locked | Locked | Locked |
Early phase clinical research services are provided in North America.
|
|
| Locked | Locked | Locked |
Biosimilars and biosuperiors are developed and commercialized in biotechnology.
|
|
| Locked | Locked | Locked |
Cardiac safety testing and respiratory laboratory services are provided.
|
|
| Locked | Locked | Locked |
Provider of testing vaccines & antivirals and CRO pharmaceutical services
|
|
| Locked | Locked | Locked |
CRO focused on early stage clinical trial research
|
Detailed competitors of CCA Clinical Research
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cca Clinical Research
Complete news archive for CCA Clinical Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CCA Clinical Research
CCA Clinical Research was founded in 1988.
CCA Clinical Research is headquartered in Cobham, United Kingdom.
CCA Clinical Research is a CRO specializing in first in-man, proof of concept and early phase clinical trials of drugs targeting neuro-muscular conditions such as ALSLou Gehrigs Disease and Huntingdons. They also claim to have expertise in clinical trials for rare diseases, neo-natal conditions and issues affecting the metabolic or endocrine systems. The company is a co-owner of PSNResearch, a CRO headquartered in the US and operations in US and Europe. Their services include study start-up, clinical trial project management and monitoring, quality assurance, protocol monitoring, regulatory support and liaison with competent authorities, ethics document management, coordination of drug distribution, site audits, management monitoring and reviews, drug safety and laboratory management.
CCA Clinical Research's top competitors include Celerion, Ask Gene Pharma and Altasciences.
CCA Clinical Research has 1 investor. Key investors include Atlantic Research Group.